Bacillus anthracis (B. anthracis) antibody and antigen (Recombinant protein)
Diagnostic antibodies (anti-Bacillus anthracis, anti-B. anthracis) and antigens (recombinant protein) for Infectious disease Bacillus anthracis detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Product information
Size: 1mg | 10mg | 100mg
Catalog No. | Description | US $ Price (per mg) | First Order Discount | First Order Discount Price |
---|---|---|---|---|
GMP-IVD-P015-Tg000-Ag01 | Recombinant Bacillus anthracis (B. anthracis) Protein | 3090 | ||
GMP-IVD-P015-Tg000-Ab01 | Anti-Bacillus anthracis (B. anthracis) mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-IVD-P015-Tg000-Ab02 | Anti-Bacillus anthracis (B. anthracis) mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-IVD-P015-Tg000-Ab03 | Anti-Bacillus anthracis (B. anthracis) human monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-IVD-P015-Tg000-Ab04 | Anti-Bacillus anthracis (B. anthracis) human monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)
Product Description
Cat No. of Products | GMP-IVD-P015-Tg000-Ag01 |
Product Name | Recombinant Bacillus anthracis (B. anthracis) Protein |
Pathogen | Bacillus anthracis |
Target/Biomarker | |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Bacillus anthracis antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Bacillus anthracis level test of Infectious disease (Anthrax) and related syndrome evaluation. |
Tag | His |
Products description | Recombinant Bacillus anthracis (B. anthracis) Protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-IVD-P015-Tg000-Ab01, GMP-IVD-P015-Tg000-Ab02 |
Product Name | Anti-Bacillus anthracis (B. anthracis) mouse monoclonal antibody (mAb) |
Pathogen | Bacillus anthracis |
Target/Biomarker | |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Bacillus anthracis antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Bacillus anthracis level test of Infectious disease (Anthrax) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-Bacillus anthracis (B. anthracis) mouse monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-IVD-P015-Tg000-Ab03, GMP-IVD-P015-Tg000-Ab04 |
Product Name | Anti-Bacillus anthracis (B. anthracis) human monoclonal antibody (mAb) |
Pathogen | Bacillus anthracis |
Target/Biomarker | |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Bacillus anthracis antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Bacillus anthracis level test of Infectious disease (Anthrax) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-Bacillus anthracis (B. anthracis) human monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Anthrax is a serious infectious disease caused by gram-positive, rod-shaped bacteria known as Bacillus anthracis. It occurs naturally in soil and commonly affects domestic and wild animals around the world. People can get sick with anthrax if they come in contact with infected animals or contaminated animal products.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.